May 25, 2018

Bio

Profile – Osemwegie (Egie) Emovon, MD FASN FACP

Medical School
College of Medicine
University of Benin, Nigeria

Internship
Department of Medicine
Howard University Hospital & Affiliated Hospitals
Washington, DC 20060

Residency
Department of Medicine
Howard University Hospital & Affiliated Hospitals
Washington, DC

Fellowship(s)
Nephrology/Clinical Hypertension
Duke University Medical Center, Durham, North Carolina

Transplant Nephrology
University of Alabama at Birmingham
Birmingham, Alabama

Board Certification/Qualifications
Satisfied UNOS Criteria, Transplant Physician, 1995
Certified in Nephrology, 1994, Re-certified in 2004
Certified in Internal Medicine 1991, Re-certified in 2002
Certified Hypertension Specialist

Medical Licensure
South Carolina, North Carolina, Pennsylvania, Mississippi and Alabama (In-active)

Membership in Professional Societies/Organizations:
Member, American Society of Transplantation, 2002
Member, kidney Council, American Heart Association, 12/01/00 – 11/30/01
Fellow, American College of Physicians 1/2000
Member, American Society of Nephrology, 1993
Member, Duke Medical Alumni, 1995
Resident Member, American Society of Internal Medicine, 1992-1995

Awards, Honors, Special Recognition:
NIH Career Enhancement Grant: Improving Indicators of Acute Rejection/Development of New Monitoring Tests using proteomics technology (Awarded: Effective date 2/1/04)
RCMAR Scholar Award 2003 -Interpretation of Borderline Renal Allograft Biopies: Impact of Ethnicity/Age on Clinical Outcome
Roche Travel Grant Award For the Tri-Annual Meeting of the South-Eastern Organ Procurement Foundation, 2002
Chief Resident (during academic year 1990/1991) Howard Medicine Service at D.C. General Hospital Washington, DC.
Outstanding Service as a Resident in Medicine at Howard Medicine Service at D.C. General Hospital Washington, DC. 6/13/91
Outstanding Resident in Medicine at Howard Medicine Service at D.C. General Hospital Washington, DC. 6/30/89

Lectures and Presentations:
“Diabetes and Kidney Transplantation” Department of Medicine Grand Rounds, given at the Medical University of South Carolina, Charleston, SC. June 22, 2004.
“Prospective use of cyclosporine pharmacokinetics in African-Americans undergoing Kidney Transplantation. Preliminary Experience.” Nephrology Seminar given at the Medical University of South Carolina, Charleston, SC. June 1, 2001.

“HLA-DQ matching in renal transplantation: What is the role of DQ incompatibility on Racial differences in Graft Survival.” Nephrology Seminar given at the Medical University of South Carolina, Charleston, SC. June 19, 1995.

Submitted Presentations:
Urea Re-circulation: Results in variability with three different techniques Presented at the 25th Annual Meeting of American society of Nephrology, November15 -18, 1992 Baltimore MD.
Characteristics of Renal Artery Stenosis In Blacks Presented at the 26th Annual meeting of American society of Nephrology, Boston, MA, November 14 -17, 1993.

Diurnal Cyclosporine Dosing Reduces the Incidence of Acute Rejection After Kidney Transplantation Presented at the 33rd Annual Scientific Meeting of American Society of Nephrology in Toronto, Ontario Canada October 13 – 16, 2000

What is the clinical significance of eosinophils in diagnostic biopsies classified as “borderline” or “suspicious” changes based on Banff 97 Schema? Presented at World Congress of Nephrology in San Francisco, 2001

Prospective use of cyclosporine pharmacokinetics reduces the incidence of acute rejection in African-Americans undergoing renal transplantation. Presented at World Congress of Nephrology in San Francisco, 2001

Renal replacement therapy in patients with sickle cell disease: A ten-year survival analysis using data from the United States Renal Data System. Presented at World Congress of Nephrology in San Francisco, 2001

Can a Pharmacokinetic Approach to Immunosuppression Eliminate Ethnic Disparities in Renal Allograft Outcome? Scientific Session of SEOPF, San Antonio, Texas January, 2002

Other Presentations:
“Malabsorption Syndrome” Medicine Conference at Howard University, 12/89
“Hypertension in ESRD” Nephrology Conference at Duke University Medical Center, 4/17/92

“Renovascular Hypertension in Blacks” Nephrology Conference at Duke University Medical Center, 9/93

“Hyper-insulinemia, Insulin Resistance and Hypertension” Nephrology Conference at Duke University, 4/2/93

“HLA-DQ Matching in Renal Transplantation and Ethnic differences in Graft Survival.” Nephrology Conference at University of Alabama at Birmingham, 1994

“The ambulatory Blood Pressure Monitor” Nephrology Conference at Duke University Medical Center, 5/94

Update on immunosuppression for kidney transplantation: lecture to community nephrologists. Greenville, SC February, 2002

Transplant-induced diabetes:Assessing and Minimizing the risk. CME lecture , MUSC Charleston, SC September 19, 2003

Extramural Professional Activities:
Contributor/Reviewer of Questions for the Certification and Re-Certification
Programs, American Board of Internal Medicine/Nephrology, 1997,1998, 1999, 2000, 2001,2002, 2003
Member, Abstract Selection Committee, World Congress of Nephrology 2003, organized jointly by ERA-EDTA and ISN, in cooperation with ESPN, EKRA, GfN and DAGKN (Berlin, Germany – June 8-12 2003)

Publications:
Journal Articles:

Osemwegie E. Emovon, Paul E. Klotman, N Reed Dunnick, Saadoon Kadir and Laura P. Svetkey. Renovascular Hypertension in Blacks. Am. J. Hypertens, 1995; 9:18-2

Laura P. Svetkey, Phillip Z. Timmons, Osemwegie Emovon, Norman B. Anderson, L. Preis, Yaun-T Song Chen. Association of Hypertension with Beta 2-adrenergic and Alpha 2c10 Receptor Genotype Hypertension, 1996; 27:1210-1215

S Smith, D Butterly, P Conlon, R Harland, O Emovon. Incidence of Cytomegalovirus Disease in Renal Transplantation without Anti-lymphocyte Induction: Is Prophylaxis Necessary? Transplantation Proceeding, 1998; 30 ,2097-2099

Barry J Browne, Cynthia Op’t Holt, Osemwegie Emovon. Diurnal Cyclosporine Dosing Optimizes Drug Exposure and Reduces the Incidence of Acute Rejection After Kidney Transplantation. Clin Transplant, 2001; 15(supl 6): 50

Emovon OE, Judy A.C. King, Cynthia Op’t Holt, Barry J Browne. Ranitidine-induced acute interstitial Nephritis in a cadaveric renal allograft. Am J Kidney Dis, 2001; 38(1):169-172
Emovon OE, Op’ t Holt C, Barry J. Browne, Can a Pharmacokinetic Approach to Immunosuppression Eliminate Ethnic Disparities in Renal Allograft Outcome? Clin Transplant. 2002;16 Suppl 7:45-8)

Morales R, Kirkpatrick M, Browne BJ, Emovon O. RSV pneumonia in an adult renal transplant patient: An unexpected nosocomial infection. Infect Control Hosp Epidemiol 2003;24:548-550

Emovon OE, Barry J. Browne. Tacrolimus and ciclosporin microemulsion in renal transplantation Letter in Lancet, 2002; 360 (9335): 799

Cummings JM, Boullier JB, Browne BJ, Bose K, Emovon O. Male Sexual Dysfunction in Renal Transplant Recipients-Comparison to Men awaiting Transplant. Transplant Proc. 2003 ;35(2):864-5

Emovon OE, Judy A. C. King, Stephen R. Smith, Cindy Op’t Holt, Freda McDonald, David N. Howell, Barry J. Browne, M.D. Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies? Clinical Nephrology 2003; 59 (2) 367 – 372

Emovon OE, Judy A.C. King, Cindy Op’t Holt, Barbara Singleton, David Howell, Barry J. Browne. Effect of Cyclosporine Pharmacokinetics on Renal Allograft Outcome in African-Americans. Clin Transplant. 2003 Jun;17(3):206-211.

Brown B.J, Op’t Holt C, Emovon OE. Delayed Graft Function may not adversely affect short-term renal allograft outcome Clin Transplant. 2003;17 Suppl 9:35-8.

Rogers J, Chavin KD, Baliga PK, Lin A, Emovon O, Afzal F, Baillie GM, Ashcraft EE, Rajagopalan PR. Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation Am. Journal of Transplantation 2003 Oct;3(10):1278-88

O.E. Emovon A. Lin, D. N. Howell, F.Afzal, M. Baillie, J.R, P.K. Baliga1, K. Chavin, V. Nickeliet, P.R. Rajagapalan, S. Self. Severe Adenovirus Infection after Simultaneous Pancreas-Kidney Transplantation: Successful Treatment with Intravenous Ribavirin and pooled human intravenous Immunoglobulin Nephro Dial Transplant 2003;18:2436

Rogers J, Chavin KD, Baliga PK, Lin A, Emovon O, Afzal F, Ashcraft EE, Baillie GM Taber DJ, and Rajagopalan PR .Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation J Gastrointest Surg. 2003 Dec;7(8):1096-101

Boughey JC, Emovon OE., Fuad Afzal, Baliga P, Jeffery Rogers J, Lin A, Chavin K, Rajagopalan PR Living Donor Transplantation of a Pelvic Kidney Clin Transplant. 2004 Jun;18(3):336-8.

Emovon OE, Rogers J, Chavin KD, Sally Self, Adenovirus in Kidney transplantation: an emerging pathogen? Transplantation. 2004 May 15;77(9):1474-5

Rogers J, Ashcraft EE, Emovon O, Baillie GM, Taber DJ, Marques RG, Baliga PK, Chavin KD, Lin A, Afzal F, and Rajagopalan PR Long-term outcome of sirolimus rescue in kidney-pancreas transplantation Transplantation 2004 Aug 27;78(4):619-22

Rogers J, Ashcraft EE, Baliga PK, Chavin KD, Lin A, Emovon O, Afzal F, Baillie GM, Taber DJ, Alvarez S, Pullatt RC, and Rajagopalan PR Transplant Proc. 2004 May;36(4):1058-60

Marques RG, Rogers J, Chavin KD, Baliga PK, Lin A, Emovon O, Afzal F, Baillie GM, Taber DJ, Ashcraft EE, and Rajagopalan PR Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc. 2004 May;36(4):1048-9.

Chapters in Scholarly Books and Monographs:
Laura P. Svetkey, Edmond O’Riordan Peter J. Conlon, Osemwegie Emovon. Genetics of Hypertension. In genetics of Cerebrovascular Disease. Mark Albert’s, (Ed). Futura Press pp 57-80, 1999

Other Publications (electronic, invited papers, CME activity, etc):
El-Khodary, M.D. and Emovon, M.D Evaluation of Endocrinopathies. Howard University Medicine Service, DC General Hospital. 1991 (Handbook for Intern’s rotating through Endocrinology Service at D.C. General Hospital).
Preparation of educational booklet for the Living related kidney transplant program at Medical University of South Carolina (NKF of South Carolina Community initiative grant, 2002)

O.E. Emovon, G. M. Baillie, P. R. Rajagopalan, K. D. Chavin. Infectious after Kidney Transplantation Medscape Continuing Medical Education Activity available on-line 12/1202 to 12/10/03

O.E. Emovon, G. M. Baillie, P. R. Rajagopalan, K. D. Chavin. Cardiovascular Disease in Hemodialysis Patients Medscape Continuing Medical Education Activity available on-line 12/1202 to 12/10/03

P.R. Rajagopalan, G.M. Baillie, O.E. Emovon, K.D. Chavin Results of the African-American Study of Kidney Disease and Hypertension (AASK) Trial Medscape Continuing Medical Education Activity available on-line 12/1202 to 12/10/03

Published Abstracts:
Emovon O.E, Collins D, Hockaday S, Schwab SJ. Urea Re-circulation: Results in Variability With Three different techniques J. Am. Soc. Nephrology 3:363, 1992
O.E. Emovon, L.P. Svetkey. Characteristics of Renal Artery Stenosis In Blacks. J. Am. Soc. Nephrology 4:531, 1993

Svetkey L.P, Timmons P.Z, Emovon O, DawsonD.V, Lefkowitz R.J, Anderson N.B, Yaun-Tsong Chen. Association between Essential Hypertension in Blacks and Genotype at the beta 2-Adrenergic Receptor Locus. The Scientific Meeting of AHA C ouncil on High Blood Pressure Research, September 1995.

S Smith, D Butterly, P Conlon, R Harland, O Emovon. Incidence of Cytomegalovirus Disease in Renal Transplantation without Anti-lymphocyte Induction: Is Prophylaxis Necessary? Presented at New Dimensions in Transplantation. Florence, Italy. February 16-19, 1998.

Emovon O.E., Op’t Holt C, Lowry R.P, Browne B.J. Diurnal Cyclosporine Dosing Reduces the Incidence of Acute Rejection after Kidney Transplantation. J. Am. Soc. Nephrology 11:686, 2000

Browne B.J, Op’t Holt C, O Emovon, Pharmacokinetic Monitoring Eliminates Racial Disparities In Acute Allograft Rejection. J. Am. Soc. Nephrology 11:681A, 2000

Browne B.J, Op’t Holt C, Emovon O.E. Diurnal Cyclosporine Dosing Optimizes Drug Exposure and Reduces the Incidence of Acute Rejection After Kidney Transplantation. Scientific Session of the Southeastern Organ Procurement Foundation, Page 10, September 14, 2000

J.A.C King, D.N Howell, F. McDonald, C.L.Op’t Holt, S.R. Smith, Emovon O.E, and B.J. Browne. Borderline Allograft Biopsies: What is the significance of Eosinophils? Modern Pathology 14:189A (Abstract 1109), 2001

Browne B.J, Op’t Holt C, Emovon O.E, 47 Consecutive Kidney Transplants without Acute Rejection-The importance of diurnal CsA dosing Am J. Transplantation 1: 183, 2001

O. Emovon, Judy A.C. King, Op’t Holt C, Barbara Singleton, David N. Howell, Browne B.J. Prospective use of cyclosporine pharmacokinetics reduces the incidence of acute rejection in African-Americans undergoing renal transplantation. J. Am. Soc. Nephrology 12: 930A (Abstract A4860), 2001

Thornley-Brown D, Emovon O.E, Akinlolu O. Ojo. Renal replacement therapy in patients with sickle cell disease: A ten-year survival analysis using data from the United States Renal Data System. J. Am. Soc. Nephrology 12: 364A (Abstract A1875), 2001

O. Emovon, JAC King, S.R. Smith, C Op’t Holt , D.N. Howell, B J. Browne. What is the clinical significance of eosinophils in diagnostic biopsies classified as “borderline” or “suspicious” changes based on Banff 97 Schema? J. Am. Soc. Nephrology 12: 887A (Abstract A4368), 2001

Morales R, Kirkpatrick M, Browne BJ, Emovon O.E, Nosocomial Respiratory Syncytial Virus infection in an adult renal transplant patient. Respiratory Care 46 (10) : 1098, 2001

Emovon O.E,Op’t Holt C, Browne B.J. Can a Pharmacokinetic Approach to Immusuppression Eliminate Ethnic Disparities in Renal Allograft Outcome? Scientific Session of the Southeastern Organ Procurement Foundation, Page 14, January 24, 2002

Cummings, Boullier, Browne BJ, Emovon O.E. Male Sexual Dysfunction in Renal Transplant Recipients-Comparison to Men awaiting Transplant. (Presented at the 2002 Annual Meeting of the American Urological Association to be held in, Orlando, Florida, May 25-30, 2002)

Browne B.J, Op’t Holt C, Emovon O.E, Diurnal CSA Dosing Eliminates Racial disparities in Short-term renal Allograft Outcome Am J Transplantation 2002:2 Abstract #545

Akinwale Olatosi, Emovon O.E, Jeffrey Rogers, Kenneth Chavin, Mark Baillie, Fuad Afzal, Prabhakar Baliga, P.R. Rajagopolan, Edwin Brown Non-pathogenic Diphteroids or Mycobaterium Tuberculosis infection?: Diagnostic pitfall in Rhodocuccus Equi infection: J. Am. Soc. Nephrology 13: PUB 531, 2002

Emovon O.E, Jeffrey Rogers, Kenneth Chavin, Mark Baillie, Angello Lin, Fuad Afzal, Prabhakar Baliga, and P.R. Rajagopalan. Assessment of Dialysis Status on Outcome after Simultaneous Pancreas-Kidney Transplantation J. Am. Soc. Nephrology 13: PUB 453, 2002

G. Mark Baille, Elizabeth E. Ashcroft, David Taber, Stephanine S. Stone, Emovon O.E, Jeffrey Rogers, Fuad Afzal, Angello Lin, P.R. Rajagopolan, Prabhakar Baliga, Kenneth Chavin. Vangancyclovir is Effective Prophylaxis for CMV High Risk Renal Transplant Recipients. J. Am. Soc. Nephrology 13: 377A, 2002

K. Chavin.,G. M Baille, E. Ashcroft, G.Magwood, J.Rogers, A Lin, P. Baliga, Emovon O.E, P.R. Rajagopolan Laparoscopic Donor Nephrectomy is safe for the Obese Living Donor J. Am. Soc. Nephrology 13: 597A, 2002

G. M. Baille, E Ashcroft C. C. Potito, E. P. Buchaanan, D. Rodwell, Emovon O.E, F. Afzal, J. Rogers, A. Lin, E.Brown, P. Baliga, P.R. Rajagopolan, K. Chavin. Incidence of CMV with Dual therapy prophylaxis in Renal Transplant Recipients J. Am. Soc. Nephrology 13: PUB 541, 2002

Olatosi A, Emovon O.E, Brown E When is a Diphtheroid not a Diphteroid ? (Presented at 40th Annual Meeting of the Infectious Diseases Society of America, October 24 – 27, 2002 in Chicago)

Browne B.J, Op’t Holt C, Emovon O.E Optimal Immunosuppression with Cyclosporine requires asymmetric Dosing Based on individual Diurnal Rhythms Am J. Transplantation 2003 suppl 5 Abstract #788

Browne B.J, Op’t Holt C, Emovon O.E Immunosuppression does not require modification in Patients with Delayed renal allograft function Am J. Transplantation 2003 suppl 5 Abstract #1390

G. M. Baille, J. H. Birsner, D. J. Taber, J. Rogers, A. Lin,, O. Emovon, F. Afzal, Drotrecogin alfa (activated) (xgristm) in abdominal organ transplant recipients with severe sepsis Am J. Transplantation 2003 suppl 5 Abstract #1399

D. J. Taber, G. M. Baillie, E. Ashcraft, C. Berman, BS, J. Rogers, A. Lin, Fuad Afzal, O. Emovon, P. Baliga, P.R. Rajagopalan, and K. D. Chavin. Bioequivalence between cyclosporine microemulsion formulations may not translate into equivalent clinical outcomes. Am J. Transplantation 2003 suppl 5 Abstract #1211

J. Rogers, K. Chavin, P. Baliga, A. Lin, S. Alvarez, O. Emovon, F. Afzal G. M. Baille, D. Taber, E. Ashcroft, P.R. Rajagopolan. Does treatment of Cadaveric Organs Donors with Desmopressin Increase The Likelehood of Pancreas Graft Thrombosis? . Am J. Transplantation 2003 suppl 5 Abstract #404

J. Rogers, K. Chavin, P.Baliga, A. Lin, R. Pullatt, O. Emovon, F. Afzal, D. Taber, G. M. Baille, , E. E. Ashcroft, P.R. Rajagopolan. Long-Term Pancreas Graft Survival Exceeds Long-Term Kidney Graft Survival In Simultanoeus Kidney-Pancreas Transplantation: Differential Effect of Chronic Calcinurin Inhibitor Therapy. Am J. Transplantation 2003 suppl 5 Abstract #666

E. Ashcraft, G. M. Baillie, D. Taber, F. Afzal, O. Emovon, A. Lin, J.Rogers, P.R. Rajagopalan, P. Baliga, K. Chavin. Cigarette Smoking Does Not Increase Operative Complications in Laparoscopic Donor Nephrectomies J. Am. Soc. Nephrology 2003 Abstract SA-PO607

G. M. Baillie, E. Ashcraft, D. Taber, F. Afzal, J. Rogers, A. Lin, O.Emovon, P.R. Rajagopalan, P. Baliga, K. Chavin. Valganciclovir Is Safe and Effective for CMV Prophylaxis in Kidney and Pancreas Transplant Recipients Who Receive Antilymphocyte Antibody Therapy J. Am. Soc. Nephrology 2003 Abstract SA-PO590